Hester Biosciences Ltd. expects about 35 percent growth in its domestic business in the next financial year, its Managing Director Rajiv Gandhi said.
The company also sees 40 percent growth in operating margins from diagnostics business, he told BloombergQuint in an interview. Gandhi also expects about 39 percent growth in operating income during the second half of the current financial year.
Watch the full interview here:
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
